Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
Clinical trial NCT03724942 · COMPLETED
Trial details
- NCT number
- NCT03724942
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2021-12-02
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.